Evidence map›Paper›PMID 42377452›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Protective in vitro effects of antioxidants against DNA damage induced by metabolites accumulated in propionic and methylmalonic acidemias.

Bianca Gomes Dos Reis, Franciele Fátima Lopes, Luísa Maria Bosquetti Tedesco, Silvia Muller de Moura Sarmento, Vanusa Manfredini, Carmen Regla Vargas

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bianca Gomes Dos ReisPrograma de Pós-Graduação Em Ciências Biológicas: Bioquímica, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. biancagomezdosreis@hotmail.com.ORCID 0000-0003-3859-9883
Franciele Fátima LopesPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-5022-3742
Luísa Maria Bosquetti TedescoPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-5223-1041
Silvia Muller de Moura SarmentoUniversidade Federal do Pampa, Uruguaiana, Brazil.ORCID 0000-0002-6872-406X
Vanusa ManfrediniUniversidade Federal do Pampa, Uruguaiana, Brazil.ORCID 0000-0002-9622-7861
Carmen Regla VargasPrograma de Pós-Graduação Em Ciências Biológicas: Bioquímica, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. crvargas@hcpa.edu.br.ORCID 0000-0002-2135-0654

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylmalonic acidemia and propionic acidemia are inborn errors of metabolism caused by genetic mutations in mitochondrial enzymes involved in propionate metabolism. When these enzymes fail to function properly, organic acids accumulate in tissues and biological fluids. The brain is the primary tissue affected in these disorders, particularly due to the accumulation of organic acids. Oxidative stress and DNA damage play an important role in the pathophysiology of these diseases and may contribute to neurological impairment. In this context, the present study aimed to evaluate the in vitro effects of L-carnitine, N-acetylcysteine, and coenzyme Q10 on DNA damage induced by metabolites accumulated in methylmalonic and propionic acidemias. Leukocytes isolated from whole blood were used, and DNA damage was assessed using the comet assay. Our results demonstrated that metabolites accumulated in these disorders were responsible for inducing DNA damage, individually and in combination. In addition, all tested antioxidants exhibited protective effects against DNA damage. This study is the first to demonstrate the genotoxic effects of other metabolites beyond methylmalonic and propionic acids and to show the protective potential effect of different antioxidants in mitigate DNA damage. Taken together, these findings reinforce the need for clinical trials evaluating antioxidant-based therapies to improve prognosis and clinical outcomes in patients with methylmalonic acidemia and propionic acidemia.

Indexed as

Amino Acid Metabolism, Inborn ErrorsAntioxidantsDNA DamagePropionatesPropionic AcidemiaAcetylcysteineCarnitineComet AssayHumansLeukocytesMethylmalonic AcidOxidative StressUbiquinoneAcetylcysteineAntioxidantsCarnitineMethylmalonic AcidPropionatesUbiquinoneAntioxidantsDNA damageMethylmalonic acidemiaOxidative stressPropionic acidemia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.